Form4insider filings, from the source

SEC Form 4 · accession 0000891293-15-000047

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Louis A Bianco
Officer — EVP, Finance & Administration
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 29, 2015S11,100$1.38D1,100,247D
Common StockSep 29, 2015S100$1.385D1,100,147D
Common StockSep 29, 2015S22,200$1.39D1,077,947D
Common StockSep 29, 2015S31,149$1.40D1,046,798D
Common StockSep 29, 2015S15,650$1.405D1,031,148D
Common StockSep 29, 2015S44,200$1.41D986,948D
Common StockSep 29, 2015S100$1.415D986,848D
Common StockSep 29, 2015S20,140$1.42D966,708D
Common StockSep 29, 2015S7,878$1.425D958,830D
Common StockSep 29, 2015S7,259$1.43D951,571D
Common StockSep 29, 2015S1,120$1.44D950,451D
Common StockSep 29, 2015S3,457$1.46D946,994D
Common StockSep 29, 2015S5,647$1.47D941,347D
Common Stockholding———37ITrust for children

Table II — derivative securities

No Table II lines on this filing.